There are additional requirements for this type of research. The Institutional BioSafety Committee of the University must first approve any gene therapy applications before they can be submitted to the IRB for approval. The proposed studies must fulfill all federal regulatory requirements before they can be undertaken. As with any protocol application, the IRB should request consultation from experts as necessary. For any approved gene transfer study, the IRB must perform continuing review at an interval not less frequently than once a year.